Proven ECZEMA Relief From Infancy On (ages 6 monthS+)
Slide to see the difference DUPIXENT made in a 4-year-old patient.
Actual 4-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met clinical trial criteria for clear or almost clear skin. Individual results may vary.
to see results
Before
Treatment
AFTER TREATMENT
With
DUPIXENT at
16 Weeks
View results in young children
Long-term safety: a year-long study in pediatrics
Long-term safety results in infants and young children aged 6 months to 5 years continuing on DUPIXENT with or without topical corticosteroids through 1 year in the pediatric extension study were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.
Most Common Side Effects in Patients With Eczema Include:
- Injection site reactions
- Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
- Cold sores in your mouth or on your lips
- High count of a certain white blood cell (eosinophilia)
These are not all the possible side effects. It is important to talk to your young child's pediatrician or eczema specialist about any and all side effects they experience. Don’t hesitate to bring up any concerns or questions you may have.